# US 2022/0033908 A1 · System and method for cleaning noisy genetic data and determining chromosome copy number

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0033908 A1
- Document ID: US20220033908A1
- Status: Published application
- Kind: A1
- Application number: 17/503,182
- Filed: 2021-10-15
- Published: 2022-02-03
- Earliest claimed: 2005-07-29
- Assignees: Natera, Inc.
- Applicants: Natera, Inc.
- Inventors: Matthew RABINOWITZ; Milena BANJEVIC; Zachary DEMKO; David JOHNSON; Dusan KIJACIC; Dimitri PETROV; Joshua SWEETKIND-SINGER; Jing XU
- Web page: https://patentgrep.com/patent/US20220033908A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- G16B 20/10: Ploidy or copy number detection
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6855: Ligating adaptors
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 25/00: ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- C12Q 2537/149: Sequential reactions
- C12Q 2545/114: involving a quantitation step
- C12Q 2600/118: Prognosis of disease development
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

Disclosed herein is a system and method for increasing the fidelity of measured genetic data, for making allele calls, and for determining the state of aneuploidy, in one or a small set of cells, or from fragmentary DNA, where a limited quantity of genetic data is available. Poorly or incorrectly measured base pairs, missing alleles and missing regions are reconstructed using expected similarities between the target genome and the genome of genetically related individuals. In accordance with one embodiment, incomplete genetic data from an embryonic cell are reconstructed at a plurality of loci using the more complete genetic data from a larger sample of diploid cells from one or both parents, with or without haploid genetic data from one or both parents. In another embodiment, the chromosome copy number can be determined from the measured genetic data, with or without genetic information from one or both parents.

## Claims

### Claim 1

A method for preparing a preparation of amplified DNA derived from one or more embryonic or fetal cells of an embryo or unborn fetus useful for reconstructing at least a portion of the genome of the embryo or fetus, comprising:
(a) extracting genomic DNA from the one or more embryonic or fetal cells;
(b) preparing a preparation of amplified DNA by amplification of a plurality of target loci from the genomic DNA extracted in (a) to obtain amplified DNA;
(c) analyzing the amplified DNA obtained in (b) by sequencing-by-synthesis to obtain genetic data of the embryo or fetus for the plurality of target loci, and reconstructing at least a portion of the genome of the embryonic or fetal cells using the genetic data of the embryo or fetus and genetic data of at least one biological parent of the embryo or fetus.

### Claim 2 (depends on 1)

The method of claim 1, wherein the extracting comprises extracting genomic DNA from one or more embryonic cells.

### Claim 3 (depends on 1)

The method of claim 1, wherein the extracting comprises extracting genomic DNA from a single embryonic cell.

### Claim 4 (depends on 1)

The method of claim 1, wherein the extracting comprises extracting genomic DNA from one or more fetal cells.

### Claim 5 (depends on 1)

The method of claim 1, wherein the extracting comprises extracting genomic DNA from one or more fetal cells isolated from a maternal blood sample or a fraction thereof.

### Claim 6 (depends on 1)

The method of claim 1, wherein the target loci comprise SNP loci.

### Claim 7 (depends on 1)

The method of claim 1, wherein the amplification comprises targeted amplification of the target loci.

### Claim 8 (depends on 1)

The method of claim 1, wherein the amplification comprises ligation of adaptors to the genomic DNA extracted in (a) followed by universal amplification.

### Claim 9 (depends on 1)

The method of claim 1, wherein the sequencing-by-synthesis comprises clonal amplification and measurement of sequences of the clonally amplified DNA

### Claim 10 (depends on 1)

The method of claim 1, wherein the reconstructing comprises reconstructing at least a portion of the genome of the embryo or fetus using the genetic data of the embryo or fetus and genetic data of both biological parents of the embryo or fetus.

### Claim 11 (depends on 1)

The method of claim 1, wherein the method further comprises determining haplotypic genetic data of the at least one biological parent of the embryo or fetus.

### Claim 12 (depends on 10)

The method of claim 10, wherein the method further comprises determining haplotypic genetic data of both biological parents of the embryo or fetus.

### Claim 13

A method for preparing a preparation of amplified DNA derived from one or more embryonic or fetal cells of an embryo or unborn fetus useful for reconstructing at least a portion of the genome of the embryo or fetus, comprising:
(a) extracting genomic DNA from the one or more embryonic or fetal cells;
(b) preparing a preparation of amplified DNA by amplification of a plurality of SNP loci from the genomic DNA extracted in (a) to obtain amplified DNA;
(c) analyzing the amplified DNA obtained in (b) by sequencing-by-synthesis to obtain genetic data of the embryo or fetus for the plurality of SNP loci, and reconstructing at least a portion of the genome of the embryonic or fetal cells using the genetic data of the embryo or fetus and genetic data of both biological parents of the embryo or fetus.
